Z-Alpha Therapeutics
PrivateLast Round
Corporate Funding
Dec 18, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Z-Alpha Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Corporate Funding round in December 2025.
Z-Alpha Therapeutics is a biotechnology company developing next-generation targeted alpha radiotherapeutics for oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Z-Alpha Therapeutics Comparables
Compare Z-Alpha Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alpha-9 Oncology | 88% | |
| ARTBIO | 86% | |
| Abdera Therapeutics | 85% |
For institutional investors. Book with your work email.
Z-Alpha Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 18, 2025 |
For institutional investors. Book with your work email.
Z-Alpha Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Corporate Funding |
| Tybourne Capital Management | Corporate Funding |
| Lilly Asia Ventures | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
Funding round included OrbiMed and Lilly Asia Ventures.
For institutional investors. Book with your work email.
Z-Alpha Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Z-Alpha Therapeutics's valuation, stock price, and market status.
Is Z-Alpha Therapeutics a public or private company?
Z-Alpha Therapeutics is a private company.
What is the current stock price of Z-Alpha Therapeutics?
Z-Alpha Therapeutics is a private company, so its shares have no public market price. Caplight tracks Z-Alpha Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Z-Alpha Therapeutics worth (valuation)?
Valuation information for Z-Alpha Therapeutics is not publicly available.
Can I buy Z-Alpha Therapeutics stock?
Z-Alpha Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Z-Alpha Therapeutics's last funding round?
Z-Alpha Therapeutics's most recent funding round was Corporate Funding on December 18, 2025.
Who are the main investors in Z-Alpha Therapeutics?
Key investors in Z-Alpha Therapeutics include OrbiMed, Tybourne Capital Management, Lilly Asia Ventures.
Will Z-Alpha Therapeutics IPO soon?
No public IPO plans have been announced for Z-Alpha Therapeutics.
How can I track Z-Alpha Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Z-Alpha Therapeutics's shares on secondary markets.